Blepharoclonus is defined as excessive, involuntary blinking of the eyes, often occurring in rapid succession. It is an extrapyramidal sign indicative of underlying neurologic dysfunction, particularly involving the basal ganglia or cerebellum.

Pathophysiology

• The basal ganglia and cerebellum play a crucial role in coordinating motor control and regulating reflexive movements.

• Lesions or dysfunction in these areas disrupt normal inhibitory and excitatory pathways, leading to involuntary eyelid contractions.

• Blepharoclonus may also appear in association with other extrapyramidal signs, such as chorea, dystonia, or myoclonus.

Examination Technique

• Patient positioning: Seated comfortably with eyes open and looking forward.

• Observation:

  1. Observe for rapid, repetitive blinking.

  2. Note the frequency, symmetry, and amplitude of eyelid movements.

  3. Assess whether blinking is continuous or intermittent, and if it worsens with stress or fatigue.

• Assessment:

  • Determine whether the excessive blinking is isolated or associated with other motor abnormalities (e.g., tremor, rigidity).

  • Document any impact on vision, daily activities, or ocular surface health.

Clinical utility

• Neurologic indicator: Suggests dysfunction of the basal ganglia or cerebellum.

• Early recognition: Helps identify patients at risk for progressive extrapyramidal disorders, such as Parkinsonism or Wilson’s disease.

• Monitoring disease progression: Frequency and severity of blepharoclonus can reflect neurologic deterioration or response to therapy.

Differential Diagnosis

Management

• Address underlying neurologic disorder: Treatment depends on the etiology (e.g., Parkinson’s disease management, discontinuation of offending drugs).

• Medications:

  • Anticholinergics, benzodiazepines, or botulinum toxin injections may reduce eyelid spasms.

• Supportive care:

  • Protect the ocular surface from irritation due to excessive blinking.

  • Educate patients about stress reduction and avoidance of triggers.

• Referral: Neurology consultation for comprehensive evaluation and management.

Pediatric considerations

• Rare in children but may occur with Tourette syndrome or basal ganglia developmental disorders.

• Differentiate from habitual blinking or attention-seeking tics.

Geriatric considerations

• More common in older adults with neurodegenerative diseases.

• Evaluate for coexisting movement disorders or medication effects.

Limitations

• Blepharoclonus is not pathognomonic for a specific disorder; it indicates neurologic dysfunction.

• Can be confused with voluntary blinking, dry eyes, or blepharospasm without proper assessment.

Patient counseling

• Explain the neurologic origin of excessive blinking.

• Discuss potential treatment options, including medications or botulinum injections.

• Encourage monitoring and follow-up for progression or emergence of other neurologic signs.

Conclusion

Blepharoclonus is a valuable clinical sign of basal ganglia or cerebellar dysfunction. Early recognition can assist in diagnosing underlying neurologic disorders, monitoring disease progression, and guiding targeted therapy to improve patient quality of life.

References

1. Jankovic J. Movement Disorders. 6th ed. Philadelphia, PA: Wolters Kluwer; 2020.

2. Buttaro TM, Tybulski J, Bailey PP, Sandberg-Cook J. Primary Care: A Collaborative Practice. St. Louis, MO: Mosby Elsevier; 2008. p. 444–447.

3. Kandel ER, Schwartz JH, Jessell TM, Siegelbaum SA, Hudspeth AJ. Principles of Neural Science. 6th ed. New York, NY: McGraw-Hill; 2021.

4. Sethi KD, Factor SA. Extrapyramidal disorders. Neurol Clin. 2005;23(1):1–18.

5. Jankovic J, Tintner R. Blepharospasm and hemifacial spasm. Neurol Clin. 2001;19(3):517–540.